Evogene, Google Cloud innovation to revolutionise ag-chemicals

Computational biology company, Evogene Ltd has developed a generative AI foundation model, version 1.0, for small molecule design, in collaboration with Google Cloud

The new model expands on Evogene's ChemPass AI by identifying novel small molecules that meet multiple complex product criteria.

Generative AI models support the agricultural industry in their small molecule discovery process by enabling the simultaneous consideration of multiple complex product requirements, all while creating truly novel molecular structures. This allows the industry to access strong, defensible IP portfolios.

Ofer Haviv, president and CEO of Evogene, said, "Completing our foundation model is a major milestone in our offering. It unlocks new frontiers for ChemPass AI, giving us the power to generate wholly novel molecules—ones that not only perform but also create new IP space. This is key to overcoming long-standing challenges in life-science R&D: from reducing late-stage failure in pharma to developing ag-chemicals that are effective, sustainable, and proprietary."

Boaz Maoz, managing director, Google Cloud Israel, said, "We're pleased to collaborate with Evogene's innovation in AI-powered molecule design. Their progress with ChemPass AI highlights the strength of pairing advanced AI infrastructure with deep scientific insight. We look forward to seeing the impact of this new model in drug discovery and agriculture."